We're double upgrading Eli Lilly after the CEO and other insiders scoop up the slumping stock
-
最新报道：Eli Lilly insiders, including CEO David Ricks and four other executives/directors, purchased company shares totaling over $3.5 million this week, signaling strong confidence after the stock's recent 20% decline. Notable purchases include Ricks ($1.05M), CSO Daniel Skovronsky ($634K), and director Erik Fyrwald ($1M) – whose investment as a non-executive board member is seen as particularly meaningful. The buying spree follows Lilly's stock drop due to disappointing trial data for its obesity pill, with shares rising 3% Wednesday on the insider activity. Market observers view these purchases as a bullish indicator since insiders typically only buy when believing shares are undervalued.
下一篇
Reveel announces REVA token economics: total supply is 1 billion, 37% allocated to the community
- According to Bijie.com, Reveel has announced the REVA token economics. The total REVA toke...
24小时热点
热点专题
413361